Anaxomics is an AI biotech company that use cutting-edge technologies based on Systems Biology to overcome challenges in drug discovery and development, specializing in In Silico Clinical Trials.
This innovative approach optimizes clinical trial efficiency and enhances our understanding of the mechanisms behind trial outcomes, thereby driving accelerated advancements in medical research.